Sialylation lessens the infectivity of Neisseria gonorrhoeae MS11 mkC

Journal of Infectious Diseases

Volumn 173, Issue 6, 1996, Pages 1422-1427

  Schneider, Herman ^a   Schmidt, Katherine A ^a   Skillman, Donald R ^a,b   Van Verg, Lillian De ^a   Warren, Richard L ^a   Wylie, Hugh J ^a   Sadoff, Jerald C ^a   Deal, Carolyn D ^a,c   Cross, Alan S ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b FITZSIMONS ARMY MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGOSACCHARIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GONORRHEA; HUMAN; HUMAN EXPERIMENT; INCUBATION TIME; MALE; NEISSERIA GONORRHOEAE; PHENOTYPE; PRIORITY JOURNAL; SIALYLATION; STRAIN DIFFERENCE; VOLUNTEER;

EID: 0029799266     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.6.1422     Document Type: Article

References (31)

1. Parsons NJ, Patel PV, Tan EL, et al. Cytidine 5′-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum. Microb Pathog 1988;5:303-9.
2. Apicella MA, Mandrell RE, Shero M, et al. Modification by sialic acid of Neisseria gonorrhoeas lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis. J Infect Dis 1990; 162:506-12.
3. Fox AJ, Curry A, Jones DM, et al. The surface structure seen on gonococci after treatment with CMP-NANA is due to sialylation of surface lipopolysaccharide previously described as a 'capsule.' Microb Pathog 1991;11:199-210.
4. Fox AJ, Curry A, Rowland PL, et al. A surface polysaccharide forms when gonococci are converted to serum resistance by cytidine 5′-monophospho-N-acetyl neuraminic acid. FEMS Microbiol Lett 1990;66: 75-80.
5. Horstmann RD. Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation. Infect Immun 1992;60:721-7.
6. Kim, JJ, Zhou D, Mandrell RE, Griffiss JM. Effect of exogenous sialylation of the lipooligosaccharide of Neisseria gonorrhoeae on opsonophago-cytosis. Infect Immun 1992;60:4439-42.
7. r factor from human red blood cells which induces gonococcal resistance to killing by human serum. J Gen Microbiol 1988;134: 3295-306.
8. Parsons NJ, Andrade JRC, Patel PV, Cole JA, Smith H. Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5′-mono-phospho-N-acetyl neuraminic acid. Microb Pathog 1989;7:63-72.
9. Parsons NJ, Cole JA, Smith H. Resistance to human serum of gonococci in urethral exudates is reduced by neuraminidase. Proc R Soc Lond [Biol] 1990;241:3-5.
10. Parsons NJ, Curry A, Fox AJ, Jones DM, Cole JA, Smith H. The serum resistance of gonococci in the majority of urethral exudates is due to sialylated lipopolysaccharide seen as a surface coat. FEMS Microbiol Lett 1992;90:295-300.
11. Wetzler LM, Barry K, Blake MS, Gotschlich EC. Gonococcal lipooligosac-charide sialylation prevents complement-dependent killing by immune sera. Infect Immun 1992;60:39-43.
12. Frosch M, Weisgerber C, Meyer TF. Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B. Proc Natl Acad Sci USA 1989;86:1669-73.
13. Mandrell RE, Lesse AJ, Sugai JV, et al. In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J Exp Med 1990;171:1649-64.
14. Mandrell RE, Smith H, Jarvis GA, Griffiss JM, Cole JA. Detection and some properties of the sialytransferase implicated in the sialylation of lipopolysaccharide of Neisseria gonorrhoeae. Microb Pathog 1993;14: 307-13.
15. Griffiss JM. The role of bacterial lipooligosaccharides in the pathogenesis of human disease. In: Trends in glycoscience and glycotechnology. 1995 (in press).
16. Griffiss JM, Wang J, Zhao S, Schneider H. Neisseria gonorrhoeae must express ganglioside-like lipooligosaccharides (LOS) to invade cervical epithelial cells [abstract B-69]. In: Proceedings of the 94th annual meeting of the American Society for Microbiology (Las Vegas). Washington, DC: ASM, 1994:41.
17. van Putten JP. Phase variation of lipopolysaccharide directs interconversion of invasive and immuno-resistant phenotypes of Neisseria gonorrhoeae. EMBO J 1993; 12:4043-51.
18. Schneider H, Cross AS, Kuschner RA, et al. Experimental human gonococcal urethritis: 250 Neisseria gonorrhoeae MSI lmkC are infective. J Infect Dis 1995;172:180-5.
19. Schneider H, Hammack CA, Apicella MA, Griffiss JM. Instability of expression of lipooligosaccharides and their epitopes in Neisseria gonorrhoeas. Infect Immun 1988;56:942-6.
20. Mandrell RE, Griffiss JM, Macher DA. Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens; carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize crossreacting antigens on LOS and human erythrocytes. J Exp Med 1988; 168:107-26.
21. Hitchcock PJ, Brown TM. Morphological heterogeneity among Salmonella chemotypes in silver-stained polyacrylamide gels. J Bacteriol 1983;154: 269-77.
22. Schneider II, Hale TL, Zollinger WD, Scid RC, Hammack CA, Griffiss JM. Heterogeneity of molecular size and antigenic expression within lipooligosaccharides of individual strains of Neisseria gonorrhoeae and Neisseria meningitidis. Infect Immun 1984;45:544-9.
23. Tsai CM, Frasch CE. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 1982;119:115-9.
24. Greaves RIN. Preservation of living cells by freeze-drying. Ann NY Acad Sci 1960;85:723-8.
25. Westphal O, Jann K. Bacterial lipopolysaccharides. In Whistler RL, ed. Methods in carbohydrate chemistry. Vol 5. Extraction with phenol-water and further application of the procedure. New York: Academic Press, 1965:83-91.
26. Schneider H, Grifliss JM, Boslego JW, Hitchcock PJ, Zahos KM, Apicella MA. Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men. J Exp Med 1991;174:1601-5.
27. Yamasaki R, Bacon BE, Nasholds W, Schneider H, Griffiss JM. Structural determination of oligosaccharides derived from lipooligosaccharide of Neisseria gonorrhoeae F62 by chemical, enzymatic, and two-dimensional NMR methods. Biochemistry 1991;30:10566-75.
28. Griffiss JM, Jarvis GA, O'Brien JP, Eads MM, Schneider H. Lysis of Neisseria gonorrhoeae initiated by binding of normal human IgM to a hexosamine-containing lipooligosaccharide epitope(s) is augmented by strain-specific, properdin-dependent-binding alternative complement pathway activation. J Immunol 1991;247:289-305.
29. Faillard H, Schauer R. Glycoproteins as lubricants, protective agents, carries, structural proteins, and participants in other functions. In: Gottschalk A, ed. Glycoproteins. Their composition, structure and function. 2nd ed. Amsterdam: Elsevier, 1972:1246-67.
30. Hakomori S. Blood group ABH and li antigens of human erythrocytes. Chemistry, polymorphism and their developmental change. Semin Hematol 1981;18:39-62.
31. Holmes KK, Johnson DW, Trostle HJ. An estimate of the risk of acquiring gonorrhea by sexual contact with infected females. Am J Epidemiol 1970;91:170-4.